Pontificia Universidad Católica de Chile Pontificia Universidad Católica de Chile
Fotaki A., Pushparajah K., Hajhosseiny R., Schneider A., Alam H., Ferreira J., Neji R., Kunze K., Frigiola A., Prieto C., Botnar R. (2023)

Free-breathing, Contrast Agent-free Whole-Heart MTC-BOOST Imaging: Single-Center Validation Study in Adult Congenital Heart Disease

Revista : Radiology-Cardiothoracic Imaging
Volumen : 5
Número : 1
Tipo de publicación : ISI Ir a publicación

Abstract

Purpose: To assess the clinical performance of the three-dimensional, free-breathing, Magnetization Transfer Contrast Bright-and-black blOOd phase-SensiTive (MTC-BOOST) sequence in adult congenital heart disease (ACHD).Materials and Methods: In this prospective study, participants with ACHD undergoing cardiac MRI between July 2020 and March 2021 were scanned with the clinical T2-prepared balanced steady-state free precession sequence and proposed MTC-BOOST sequence. Four cardiologists scored their diagnostic confidence on a four-point Likert scale for sequential segmental analysis on images acquired with each sequence. Scan times and diagnostic confidence were compared using the Mann-Whitney test. Coaxial vascular dimensions at three anatomic landmarks were measured, and agreement between the research sequence and the corresponding clinical sequence was assessed with Bland-Altman analysis.Results: The study included 120 participants (mean age, 33 years +/- 13 [SD]; 65 men). The mean acquisition time of the MTC-BOOST sequence was significantly lower compared with that of the conventional clinical sequence (9 minutes +/- 2 vs 14 minutes +/- 5; P < .001). Diagnostic confidence was higher for the MTC-BOOST sequence compared with the clinical sequence (mean, 3.9 +/- 0.3 vs 3.4 +/- 0.7; P < .001). Narrow limits of agreement and mean bias less than 0.08 cm were found between the research and clinical vascu-lar measurements.Conclusion: The MTC-BOOST sequence provided efficient, high-quality, and contrast agent-free three-dimensional whole-heart imag-ing in ACHD, with shorter, more predictable acquisition time and improved diagnostic confidence compared with the reference stan-dard clinical sequence.